Skip to main content

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrahams I, McCarthy JT, Sanders SL (1963) 101 cases of exfoliative dermatitis. Arch Dermatol 87:96–101

    PubMed  CAS  Google Scholar 

  2. Sigurdsson V, Steegmans PHA, Van Vloten WA (2001) The incidence of erythroderma: a survey among all dermatologists in the Netherlands. J Am Acad Dermatol 45:675–678

    Article  PubMed  CAS  Google Scholar 

  3. Mutasim DF (2003) Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae. J Am Acad Dermatol 48:947–949

    Article  PubMed  Google Scholar 

  4. Pierson JC, Taylor JS (1993) Erythrodermic dermatomyositis. J Am Acad Dermatol 28:136

    Article  PubMed  CAS  Google Scholar 

  5. Janniger CK, Gascon P, Schwartz RA et al (1991) Erythroderma as the initial presentation of the acquired immunodeficiency syndrome. Dermatologica 183:143–145

    Article  PubMed  CAS  Google Scholar 

  6. Sadick NS, McNutt NS, Kaplan MH (1990) Papulosquamous dermatoses of AIDS. J Am Acad Dermatol 22:1270–1277

    Article  PubMed  CAS  Google Scholar 

  7. Zip C, Murray S, Walsh NMG (1993) The specificity of histopathology in erythroderma. J Cutan Pathol 20: 393–398

    Article  PubMed  CAS  Google Scholar 

  8. Alonso-Llamazares J, Dietrich SM, Gibson LE (1998) Bullous pemphigoid presenting as exfoliative dermatitis. J Am Acad Dermatol 39:827–830

    Article  PubMed  CAS  Google Scholar 

  9. Sentis HJ, Willemze R, Sheffer E (1986) Histopathologic studies of Sezary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 15:1217–1226

    Article  PubMed  CAS  Google Scholar 

  10. Abel EA, Lindae ML, Hoppe TR et al (1988) Benign and malignant forms of erythroderma: cutaneous immunophenotypic characteristics. J Am Acad Dermatol 19:1089–1095

    Article  PubMed  CAS  Google Scholar 

  11. Cherny S, Mraz S, Su L et al (2001) Heteroduplex analysis of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for erythroderma. J Cutan Pathol 28:351–355

    Article  PubMed  CAS  Google Scholar 

  12. Cordel N, Lenormand B, Courville P et al (2001) Detection of clonal T-cell receptor gamma gene rearrangement with the use of PCR-PGDE for diagnosis of erythroderma. Ann Dermatol Venereol 128:220–223

    PubMed  CAS  Google Scholar 

  13. Pal S, Haroon TS (1998) Erythroderma: a clinicoetiologic study of 90 cases. Int J Dermatol 37:104–107

    Article  PubMed  CAS  Google Scholar 

  14. Asai T, Horiuchi Y (1989) Senile erythroderma with serum hyper-IgE. Int J Dermatol 28:225–228

    Article  Google Scholar 

  15. Wilson DC, Jester JD, King LE (1993) Erythroderma and exfoliative dermatitis. Clin Dermatol 11:67–72

    Article  PubMed  CAS  Google Scholar 

  16. Wong KS, Wong SN, Tham SN et al (1988) Generalized exfoliative dermatitis: a clinical study of 108 patients. Ann Acad Med Singapore 17:520–523

    PubMed  CAS  Google Scholar 

  17. Li LF, Ma C (2006) Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. Clin Exp Dermatol 31:642–647

    Article  PubMed  Google Scholar 

  18. Holme SA, Roberts DL (2000) Erythroderma associated with St. John's wort. Br J Dermatol 143:1127–1128

    Article  PubMed  CAS  Google Scholar 

  19. King LE (1994) Erythroderma: who, where, when, why and how? Arch Dermatol 130:1545–1547

    Article  PubMed  Google Scholar 

  20. King LE, Dufresne RG, Lovett GL et al (1986) Erythroderma: a review of 82 cases. South Med J 79:1210–1215

    Article  PubMed  Google Scholar 

  21. Peyriere H, Dereure O, Breton H et al. (2006) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 155:422–428

    Article  PubMed  CAS  Google Scholar 

  22. Shiohara T, Inaoka M, Kano Y (2006) Drug-induced hyper-sensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int. 55:1–8

    Article  PubMed  Google Scholar 

  23. White JML, Smith CH, Robson A et al. (2008) DRESS syndrome caused by efalizumab. Clin Exp Dermatol 33:50–52

    PubMed  CAS  Google Scholar 

  24. Vonderheid EC, Bernengo MG, Burg G et al (2002) Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46:95–106

    Article  PubMed  Google Scholar 

  25. Rosen T, Chappell R, Drucker C (1979) Exfoliative dermatitis: presenting sign of internal malignancy. South Med J 72:652–653

    PubMed  CAS  Google Scholar 

  26. Nousari HC, Kimyai-Asadi A, Spegman DJ (1998) Paraneoplastic dermatomyositis presenting as erythroderma. J Am Acad Dermatol 39:653–654

    Article  PubMed  CAS  Google Scholar 

  27. Pruszkowski A, Bodemer C, Fraitag S et al (2000) Neonatal and infantile erythrodermas: a retrospective study of 51 patients. Arch Dermatol 136:875–880

    Article  PubMed  CAS  Google Scholar 

  28. Rothe MJ, Bialy TL, Grant-Kels JM (2000) Erythroderma. Dermatol Clin 18:405–415

    Article  PubMed  CAS  Google Scholar 

  29. Gupta R, Khera V (2001) Erythroderma due to dermatophyte. Acta Derm Venereol 81:70

    Article  PubMed  CAS  Google Scholar 

  30. Botella-Estrada R, Sanmartin O, Oliver V et al (1994) Erythroderma: a clinicopathological study of 56 cases. Arch Dermatol 130:1503–1507

    Article  PubMed  CAS  Google Scholar 

  31. Hasan T, Jansen CT (1983) Erythroderma: a follow-up of 50 cases. J Am Acad Dermatol 8:836–840

    Article  PubMed  CAS  Google Scholar 

  32. Sigurdsson V, Toonstra J, Hezemans-Boer M et al (1996) Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival. J Am Acad Dermatol 35:53–57

    CAS  Google Scholar 

  33. Thestrup-Pedersen K, Halkier-Sorensen L, Sogaard H et al (1988) The red-man syndrome: exfoliative dermatitis of unknown aetiology-a description and follow-up of 38 patients. J Am Acad Dermatol 18:1307–1312

    Article  PubMed  CAS  Google Scholar 

  34. Zoon JJ, Mali JWH (1957) The influence of erythroderma on the body. Arch Dermatol 75:573–578

    CAS  Google Scholar 

  35. Fox RH (1967) Temperature regulation in erythroderma. J R Coll Phys Lond 1:372–379

    Google Scholar 

  36. Leading article (1983) Haemodynamics of extensive skin disease. Lancet 1:1144

    Google Scholar 

  37. Krook G (1960) Hypothermia in patients with exfoliative dermatitis. Acta Derm Venereol (Stockh) 40:142

    CAS  Google Scholar 

  38. Marks J, Shuster S (1966) Method for measuring capillary permeability and its use in patients with skin disease. BMJ 2:88–90

    Article  Google Scholar 

  39. Shuster S (1967) Systemic effects of skin disease. J R Coll Phys Lond 1:345–355

    Google Scholar 

  40. Worm AM, Taaning E, Rossing N (1981) Distribution and degradation of albumin in extensive skin disease. Br J Dermatol 104:389–396

    Article  PubMed  CAS  Google Scholar 

  41. Shuster S, Wilkinson P (1963) Protein metabolism in exfoliative dermatitis and erythroderma. Br J Dermatol 75:344–353

    Article  PubMed  CAS  Google Scholar 

  42. Freedberg IM, Baden HP (1962) The metabolic response to exfoliation. J Invest Dermatol 38:277–284

    PubMed  CAS  Google Scholar 

  43. Boyd AS, Menter A (1989) Erythrodermic psoriasis. Precipitating factors, course and prognosis in 50 patients. J Am Acad Dermatol 21:985–991

    Article  PubMed  CAS  Google Scholar 

  44. Byer RL, Bachur RG (2006) Clinical deterioration among patients with fever and erythroderma. Pediatrics 118:2450–2460

    Article  PubMed  Google Scholar 

  45. Russell-Jones R, Whittaker S (1999) T-cell receptor gene analysis in the diagnosis of Sézary syndrome. J Am Acad Dermatol 41:254–259

    Article  PubMed  CAS  Google Scholar 

  46. Russell-Jones R, Whittaker S (2000) Sezary syndrome: diagnostic criteria and therapeutic options. Semin Cutan Med Surg 19:100–108

    Article  PubMed  CAS  Google Scholar 

  47. Russell-Jones R (2005) Diagnosing erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 153:1–5

    Article  PubMed  Google Scholar 

  48. Bernengo MG, Levi L, Zina G (1981) Skin lesions in angioimmunoblastic lymphadenopathy. Br J Dermatol 104:131–139

    Article  PubMed  CAS  Google Scholar 

  49. Thomson MA, Berth-Jones J, Erythroderma X (2006) In: Lebwohl M, Heymann WR, Berth-Jones J, Coulson I (eds.) Treatment of Skin Disease: Comprehensive Therapeutic Strategies. Mosby, St. Louis

    Google Scholar 

  50. Boffa MJ, Chalmers RJ (1996) Methotrexate for psoriasis. Clin Exp Dermatol 21:399–408

    Article  PubMed  CAS  Google Scholar 

  51. Roeder C, Driesch PV (1999) Psoriatic erythroderma and bullous pemphigoid treated successfully with acitretin and azathioprine. Eur J Dermatol 9:537–539

    PubMed  CAS  Google Scholar 

  52. Studio italiano multicentrico nella psoriasi (1993) Management or erythrodermic psoriasis with low-dose cyclosporin. Dermatology 187(1):30–37

    Google Scholar 

  53. Prossick TA, Belsito DV (2006) Alefacept in the treatment of recalcitrant palmoplantar and erythrodermic psoriasis. Cutis 78:178–180

    PubMed  Google Scholar 

  54. Poulalhon N, Begon E, Lebbé C et al (2007) A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Br J Dermatol 156:329–336

    Article  PubMed  CAS  Google Scholar 

  55. Sterry W, Muche JM, Erythroderma (2003) In: Bolognia JL, Jorizzo JL, Rapini RP (eds.) Dermatology. Mosby, St. Louis

    Google Scholar 

  56. Marsden JR, Rajpar SF, Mycoses F (2006) In: Lebwohl M, Heymann WR, Berth-Jones J, Coulson I (eds.) Treatment of Skin Disease: Comprehensive Therapeutic Strategies. Mosby, St. Louis

    Google Scholar 

  57. Russell-Jones R, Whittaker S (2000) Sezary syndrome: diagnostic criteria and therapeutic options. Semin Cutan Med Surg 19:100–108

    Article  PubMed  CAS  Google Scholar 

  58. Duvic M, Hester JP, Lemak NA (1996) Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 35:573–579

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thomson, M.A., Berth-Jones, J. (2009). Erythroderma and Exfoliative Dermatitis. In: Revuz, J., Roujeau, JC., Kerdel, F.A., Valeyrie-Allanore, L. (eds) Life-Threatening Dermatoses and Emergencies in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79339-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79339-7_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79338-0

  • Online ISBN: 978-3-540-79339-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics